Part 3 of our Fostering Life Science Innovation series explores how universities can drive early-stage innovations forward through continued incubation, creative funding, and flexible pathways to commercialization.
https://t.co/lcO0ZJAKYL
Enhance Diagnostics is pleased to announce Dr. Matthew Leming as new CEO, with FDA Breakthrough Device designation for Breeze, the company is poised to advance life-changing diagnostic solutions
https://t.co/ae5zQ9Kl1R
Our November newsletter is out now, featuring fresh insights on moving university innovations toward commercialization, portfolio company milestones across diagnostics and medical devices and much more.
https://t.co/0QYcPDzEXd
With a diverse background spanning emergency, forensic, and family medicine, Dr. Anakor's journey reflects a deep commitment to patient-centered care. Transitioning into clinical development, she now leads global immunology trials
Read the full interview: https://t.co/4NiWRZXDlh
With a wealth of experience in launching innovative life sciences products and leading global teams, Alex's expertise will be invaluable as we continue to advance transformative healthcare technologies
https://t.co/vJOxOG613D
Focusing on biomedical innovations that target the biological aging process and contribute to healthy longevity has seen a five-year average for investment that quadrupled in the past decade.
https://t.co/rsEWyiNDj9
From early research to successful exit, the funding landscape in life sciences is complex but it doesnβt have to be confusing. Hereβs a clear roadmap to help investors and innovators make smarter moves at every stage.
https://t.co/7o5nZ957T4
From lab to impact: Alberto Schena of Knowledge Transfer UNIL CHUV shares how science becomes real-world innovation, from licensing breakthroughs to advancing global health
https://t.co/se2SNrDAGJ
One week to go! Join our VIC Investor Network webinar with Solenic Medical, pioneering non-invasive implant infection treatment with their FDA Breakthrough Device.
Oct 29 | Register: https://t.co/qEb9nPOEES
Whether you're a founder, investor, or scientist, the VIC Journal provides a rare window into the evolving landscape of life science innovation. Explore seven years of expert-authored articles on commercialization, funding, and the future of healthcare.
https://t.co/cTnJmB9T7E
Congratulations to VIC Tech portfolio company Cellia Science on the recent SBIR grant, which will fund development of a rapid diagnostic to detect spontaneous bacterial peritonitis, a serious infection affecting patients with advanced liver disease.
https://t.co/d8iGrmzNlH
We are please to welcome Dr. Jeff White to our strategic advisory board, White brings more than 25 years of experience driving MedTech development, innovation, and commercialization across early- and late-stage ventures. Welcome to the team!
https://t.co/5MJ4HEVAmk
The life sciences are facing structural disruptions in 2025, including funding cuts, lawsuits, supply-chain risks, and intensified global competition. We explore how agility is key to survival and growth.
https://t.co/NFT5sVSlpK
Join the Oct 29 VIN Webinar featuring Solenic Medical! Their FDA Breakthrough Device uses alternating magnetic fields to treat implant infections, offering a safer alternative to risky surgeries.
π Register here: https://t.co/SMWABXgv6E
The grant will support development of a novel, non-invasive breath diagnostic tool to improve monitoring and care for individuals living with urea cycle disorders.
https://t.co/8ToupPDm1F
Our September newsletter is live!
From navigating uncertainty in the life sciences to bridging science and industry, plus fresh portfolio updates, industry insights, and upcoming events, you wonβt want to miss this issue.
Read it here: https://t.co/zANELcHNYx